Hear FDA discuss the goals and commitments for their Centers, the changes of emphasis, and the potential impact on future programs. Reactor panels provide the exchange of views on what the UFA provisions will mean for innovation, how they will improve patient access to needed medical products over the next five years, and next steps in preparing for 2017.

FDA, industry, patient, consumer, and healthcare professional group representatives, discuss the key PDUFA V commitments, current plans for their implementation, and potential impact on all stakeholders.